Geneuro
GeNeuro develops innovative treatments against inflammatory and degenerative disorders associated with endogenous retroviruses.
Total raised
€29M
€28,500,000
Funding rounds
3
Investors
0
distinct backers
Active since
2020-01
latest 2024-02
Funding by year
EUR raised per yearSignals
Medium confidenceRaise-next likelihood20
base rate 30% for Other
- ▼ Overdue vs cohort gap
- ▼ Down/flat last round
Exit likelihood16
base rate 12% (2+ rounds)
- ▲ 3 rounds raised
- ▲ 20y since founding
Timing: overdue vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-02-06 | Other | €5.0M | — | View deal → |
| 2021-07-16 | Other | €6.0M | — | View deal → |
| 2020-01-31 | Other | €18M | — | View deal → |
Related news
- GeNeuro raises 6 million euros in a private placementstartupticker.ch · 2021-07
- siliconcanals.com
- startupticker.ch
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy